Un asterisco sulla prima colonna indica che, per la prova corrispondente, č attiva una sospensione dell'accreditamento per quella prova (cfr. RG-02, §6).
NOTA: Le prove accreditate con campo flessibile, sono indicate come tali nella terza colonna. Il dettaglio delle prove flessibili, gestito dal laboratorio sotto la propria responsabilitā, č distinto con l'indicazione "prova correlata".
| S. | Cat. | Materiale / Prodotto / Matrice | Misurando / Proprietā misurata / Denominazione della prova | Norma/metodo di prova | Tecnica di prova | Campo di misura e/o di prova | |
|---|---|---|---|---|---|---|---|
| 0 | Campioni biologici/Biological samples, Reperti/Exhibits | Polimorfismi genetici del DNA/DNA polymorphism genetics, Tipizzazione DNA umano/Human DNA typing (65-500 bp) | PSBF001 Rev11 2024 | Elettroforesi capillare | |||
| 0 | Matrice cheratinica umana/Human keratin matrix | 11-nor-9-carbossi- Delta-9-tetraidrocannabinolo (THC-COOH)/11-nor-9-carboxy Delta-9-Tetrahydrocannabinol (THC-COOH), Delta-9-Tetraidrocannabinolo (THC)/Delta-9-Tetrahydrocannabinol (THC) (> 20 pg/mg per THC, > 0.2 pg/mg per THC-COOH) | PSCH034 Rev13 2024 | UHPLC-MS/MS | |||
| 0 | Matrice cheratinica umana/Human keratin matrix | 2-etilden-1,5dimetil-difenilpirrolidina (EDDP)/2-ethylidene-1,5dimethyl-diphenylpyrrolidine (EDDP), 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossietilamfetamina (MDEA)/3-4-Methylenedioxyethylamphetamine (MDEA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Benzoilecgonina (BZE)/Benzoylecgonine (BZE), Buprenorfina/Buprenorphine, Cocaetilene/Cocaethylene, Cocaina/Cocaine, Codeina/Codeine, Ketamina/Ketamine, Metadone/Methadone, Morfina/Morphine, Nor-buprenorfina/Nor-buprenorphine, Nor-ketamina/Nor-ketamine (> 0.1 ng /mg, > 0.01 ng /mg per Buprenorfina e Nor-Buprenorfina, > 0.05 ng /mg per BZE e Cocaetilene) | PSCH055 Rev3 2024 | UHPLC-MS/MS | |||
| 0 | Matrice cheratinica umana/Human keratin matrix | 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossietilamfetamina (MDEA)/3-4-Methylenedioxyethylamphetamine (MDEA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Amfetamina/Amphetamine, Benzoilecgonina (BZE)/Benzoylecgonine (BZE), Buprenorfina/Buprenorphine, Cocaetilene/Cocaethylene, Cocaina/Cocaine, Codeina/Codeine, Delta-9-Tetraidrocannabinolo (THC)/Delta-9-Tetrahydrocannabinol (THC), Ketamina/Ketamine, Metadone/Methadone, Metamfetamina (MAMP)/Methamphetamine (MAMP), Morfina/Morphine (> 0.1 ng /mg /; > 0.01 ng /mg per Buprenorfina; > 0.025 ng /mg per Ketamina, BZE e THC) | PSCH043 Rev5 2024 | UHPLC-MS/MS | |||
| 0 | Matrice cheratinica umana/Human keratin matrix | Etilglucuronato (ETG)/Ethylglucuronide (> 10 pg /mg /) | PSCH037 Rev11 2024 | UHPLC-MS/MS | |||
| 0 | Sangue intero umano/Human whole blood | 11-idrossi-Delta 9-tetraidrocannabinolo (THC-MET)/11-hydroxy-Delta-9-Tetrahydrocannabinol (THC-MET), 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Amfetamina/Amphetamine, Buprenorfina/Buprenorphine, Cocaetilene/Cocaethylene, Cocaina/Cocaine, Codeina/Codeine, Delta-9-Tetraidrocannabinolo (THC)/Delta-9-Tetrahydrocannabinol (THC), Ketamina/Ketamine, Metadone/Methadone, Metamfetamina (MAMP)/Methamphetamine (MAMP), Morfina/Morphine (> 5ng/mL per Cocaina, 6-MAM, Morfina, Metadone, Codeina, Cocaetilene e Ketamina, > 10 ng/mL per Amfetamina, MDA, MAMP, MDMA, > 1 ng/mL per Buprenorfina, THC e THC-MET) | PSCH045 Rev7 2024 | UHPLC-MS/MS | |||
| 0 | Sangue intero umano/Human whole blood | Etanolo (Alcol etilico)/Ethanol (Ethyl alcohol) ( > 0,10 g/L ) | PSCH039 Rev7 2024 | GC-MS | |||
| 0 | Siero di sangue umano/Human blood serum | Transferrina carboidrato carente (CDT) /Carbohydrate-Deficient Transferrin (>0.6%) | PSCC006 Rev12 2022 | HPLC-UV-vis | |||
| 0 | Urina umana/Human urine | 11-nor-9-carbossi- Delta-9-tetraidrocannabinolo (THC-COOH)/11-nor-9-carboxy Delta-9-Tetrahydrocannabinol (THC-COOH) (> 10 ng/mL) | PSCH009 Rev11 2024 | UHPLC-MS/MS | |||
| 0 | Urina umana/Human urine | 2-etilden-1,5dimetil-difenilpirrolidina (EDDP)/2-ethylidene-1,5dimethyl-diphenylpyrrolidine (EDDP), Metadone/Methadone (> 100 ng/ mL) | PSCH033 Rev8 2024 | GC-MS | |||
| 0 | Urina umana/Human urine | 2-idrossietilflurazepam/2-idrossietilflurazepam, 7-aminoclonazepam/7-aminoclonazepam, 7-aminoflunitrazepam/7-aminoflunitrazepam, 7-aminonitrazepam/7-aminonitrazepam, Alfa-idrossialprazolam/Alfa-idrossialprazolam, Alfa-idrossimidazolam/Alfa-idrossimidazolam, Alfa-idrossitriazolam/Alfa-idrossitriazolam, Alprazolam/Alprazolam, Bromazepam/Bromazepam, Clonazepam/Clonazepam, Delorazepam/Delorazepam, Demoxepam/Demoxepam, Desalchilflurazepam/Desalchilflurazepam, Diazepam/Diazepam, Fenobarbital/Fenobarbital, Flunitrazepam/Flunitrazepam, Lorazepam/Lorazepam, Lormetazepam/Lormetazepam, Midazolam/Midazolam, Nordiazepam/Nordiazepam, Oxazepam/Oxazepam, Prazepam/Prazepam, Secobarbital/Secobarbital, Temazepam/Temazepam, Triazolam/Triazolam, Zolpidem/Zolpidem, Zopiclone/Zopiclone (> 50 ng/mL) | PSCH032 Rev9 2024 | UHPLC-MS/MS | |||
| 0 | Urina umana/Human urine | 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), Amfetamina/Amphetamine, Ketamina/Ketamine, Metamfetamina (MAMP)/Methamphetamine (MAMP), Nor-ketamina/Nor-ketamine (> 100 ng/mL) | PSCH056 rev3 2024 | UHPLC-MS/MS | |||
| 0 | Urina umana/Human urine | 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Codeina/Codeine, Morfina/Morphine, Ossicodone/Oxycodone, Ossimorfone/Oxymorphone (> 50 ng/mL Morfina, Codeina, Ossimorfone, Ossicodone; > 5 ng/mL 6-Monoacetilmorfina (6-MAM)) | PSCH013 Rev12 2024 | UHPLC-MS/MS | |||
| 0 | Urina umana/Human urine | Benzoilecgonina (BZE)/Benzoylecgonine (BZE), Cocaetilene/Cocaethylene (> 50 ng/mL) | PSCH024 Rev12 2024 | GC-MS | |||
| 0 | Urina umana/Human urine | Buprenorfina/Buprenorphine, Nor-buprenorfina/Nor-buprenorphine (> 5 ng /mL) | PSCH054 Rev4 2024 | UHPLC-MS/MS |